More on AEON
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.30 |
|
|||
| Open | $0.28 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $0.29 | ||||
| Day Low | $0.26 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 297,468 | ||||
- AEON Biopharma to Participate in Lake Street Capital Markets’ 10th Annual Best Ideas Growth (BIG10) Conference
- AEON Biopharma names ex-FDA neuroscience official as acting CRO
- AEON Biopharma Designates Former FDA Neuroscience Leader Paul Lee, M.D., Ph.D. as Acting Chief Regulatory Officer
- Form 4 AEON Biopharma, Inc. For: Aug 19 Filed by: LYNCH TIMOTHY P
- Form 3 AEON Biopharma, Inc. For: Aug 19 Filed by: LYNCH TIMOTHY P
- AEON Reports Expanded Structural Data Supporting Molecular Similarity of ABP-450 to BOTOX®
- AEON Biopharma, Inc (AEON) PT Lowered to $1.20 at H.C. Wainwright
- AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update
- AEON Biopharma regains NYSE American listing compliance
- AEON Biopharma Regains Compliance with NYSE American Continued Listing Standards
Entities mentioned with AEON
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- Definitive Agreement | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Show More...
